Doctors track patients for years after bone marrow drug trial
NCT ID NCT04870346
Summary
This study is checking on patients for up to five years after they finished a previous trial for a drug called romiplostim, which treats aplastic anemia. The goal is to see if the treatment's benefits last long-term and to watch for any delayed side effects or health changes. It involves 36 patients who were in the earlier trials and does not involve giving them any new treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for APLASTIC ANEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Kanazawa University, College of Medical Pharmaceutical and Health Sciences, School of Medicine, Department of Hematology
Kanazawa, Ishikawa-ken, 920-0934, Japan
Conditions
Explore the condition pages connected to this study.